Recently, the realm of diabetes treatment has witnessed a wave of innovation with the development of novel drugs mimicking GLP-1. Among these groundbreaking advancements are retatrutide and trizepatide, two https://oisibpya611849.pointblog.net/glp-1-receptor-agonists-retatrutide-and-trizepatide-88530017